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Abstract
Following a radiological or nuclear emergency, first responders and the public may become 
internally contaminated with radioactive materials, as demonstrated during the Goiânia, Chernobyl 
and Fukushima accidents. Timely monitoring of the affected populations for potential internal 
contamination, assessment of radiation dose and the provision of necessary medical treatment are 
required to minimize the health risks from the contamination. This paper summarizes the 
guidelines and tools that have been developed, and identifies the gaps and priorities for future 
projects.
INTRODUCTION
Capacity to respond to radiological and nuclear (RN) emergencies is included in the list of 
core national capacities under the International Health Regulations (IHR 2005)(1). Following 
an RN emergency, first responders and the public may become internally contaminated with 
radioactive materials by breathing the contaminated air, consuming the contaminated food/
water or being wounded by a sharp object/debris contaminated with radioactive materials. 
Timely screening for potential internal contamination, assessing the intake and radiation 
dose, providing necessary medical intervention and monitoring its efficacy are essential 
components of immediate and near-term emergency consequence management.
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WHO manages a global network called the Radiation Emergency Medical Preparedness and 
Assistance Network (REMPAN), designated to assist WHO in providing technical assistance 
to its 194 member states in the area of preparedness and response to an RN emergency(2). At 
the 14th WHO REMPAN Coordination and Planning Meeting held at the University of 
Wurzburg, Germany, 7–9 May 2014, it was proposed and supported by the network 
members to set up an informal working group (WG) to address research and development 
issues pertaining to managing internal radiation contamination: screening for potential 
contamination, internal dose assessment and clinical management. The objective of this WG 
is to facilitate collaboration among the participating institutions of the REMPAN:
a. Review the current landscape in the area of internal contamination monitoring, 
assessment and management, and identifying potential gaps and priority topics 
where further research is required and can benefit from international cooperation.
b. Conduct collaborative projects to fill the knowledge and operational gaps in 
emergency population monitoring, internal radiation assessment and dosimetry, 
and medical management of internal contamination.
c. Assist WHO Radiation Program and REMPAN member institutions by ensuring 
access to consistent, high quality technical advice on the management of internal 
contamination.
d. Assist REMPAN collaborating centers and liaison institutions in developing their 
capabilities in the above mentioned technical areas.
e. Mobilize joint resources for the network’s activities/meetings.
This paper first reviews the available publications and current projects relevant to managing 
internal radiation contamination, and then identifies potential working areas the WG may 
focus on in the coming years.
PUBLICATIONS AND CURRENT PROJECTS RELATED TO MANAGING 
INTERNAL RADIATION CONTAMINATION
There are numerous publications and tools developed to address the management of internal 
contamination for occupational situations or for emergency situations. Notably, the National 
Council on Radiation Protection and Measurement (NCRP) Report 161 and Report 166 
provide a comprehensive review and guidance on managing people contaminated with 
radionuclides, including population monitoring, clinical decision guides and radionuclide 
decorporation(3, 4). Public Health England (PHE) has developed a guidance document on 
screening people for internal radioactive contamination(5), practical guidelines on thyroid 
monitoring for radioiodine using handheld instruments(6) and a software tool for the rapid 
calculation of internal dose from measurements of people in an emergency(7). In addition, 
the U.S. Centers for Disease Control and Prevention (CDC) is developing the Internal 
Contamination Assessment Tool software for screening internal contamination (early triage) 
using handheld instruments and portal monitors, the International Atomic Energy Agency 
(IAEA) is developing a guidance document on the medical management of internal 
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contamination, while the World Health Organization (WHO) is revising its 1999 guidelines 
for iodine prophylaxis following nuclear accidents.
The IAEA and the International Organization for Standardization (ISO) have published 
methods and standards for monitoring and assessing occupational radiation exposure due to 
intake of radionuclides(8–15). These methods, standards and guides provide useful 
information for managing internal contamination following an emergency although the 
methodology and approach for managing internal contamination for emergency situations 
are different than those for occupational situations. For emergency situations, monitoring 
and assessment must be carried out quickly and in a robust manner, since a potentially large 
population of physically diverse individuals needs to be screened and assessed in a short 
period of time. As a result, the dose thresholds and the required sensitivities and accuracies 
for the monitoring and assessment methods are less restrictive than those used for 
occupational situations,
Other publications, although not specifically addressing the management of internal 
contamination, cover the essential aspects of population monitoring and medical 
management following an RN emergency. These include the second edition of the 
Population Monitoring Guide of the U.S. CDC(16), the third edition of the Medical Aspects 
of Radiation Incidents published by the Radiation Emergency Assistance Centre/Training 
Site (REAC/TS)(17), the TMT Handbook(18), the Radiation Emergency Medical 
Management (REMM) online tool(19), the IAEA safety criteria for use in preparedness for 
and response to a nuclear or radiological emergency(20), the IAEA generic procedures for 
medical response during a nuclear or radiological emergency(21), the IAEA actions to 
protect the public in an emergency due to severe conditions at a Light Water Reactor(22) and 
the respective health hazard charts(23), and three publications from the International 
Commission on Radiological Protection (ICRP) on the principles of protecting people 
during an RN emergency(24–26). These publications provide guidance on a wide range of 
activities including the monitoring and medical management of people who may be 
internally contaminated with radionuclides.
EMERGENCY POPULATION MONITORING FOR INTERNAL RADIATION 
CONTAMINATION
Population monitoring is an essential element of the response to an RN emergency. It starts 
soon after an RN emergency is reported. The key objectives of population monitoring are to
a. identify individuals whose health may be in immediate danger and may need 
immediate medical care or decontamination,
b. identify individuals who may need medical treatment for radiation exposure or 
contamination, further evaluation, or short-term health monitoring,
c. recommend and, to the extent possible, facilitate treatments that may reduce the 
risk of future health consequences of radiation exposure or contamination,
d. register potentially affected populations for long-term health monitoring, and
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e. provide assurance to individuals who are not exposed or contaminated.
Some guidelines have been developed for population monitoring following an RN 
emergency(4, 16, 18). However, this WG recognized that, although these elaborate guidelines 
provide detailed scientific or regulatory recommendations, practical yet short manuals are 
more useful to the first responders and medical personnel when they perform population 
monitoring. Current guidelines should be reviewed and evaluated for their applicability and 
limitations. Available protocols may need to be harmonized; these protocols can also be used 
as a basis for short manuals and check lists (no more than a few pages each). Applications 
for handheld devices may need to be developed with practical information that responders 
can use, focusing on three major areas:
a. initial sorting for highly contaminated casualties,
b. early triage for internally contaminated casualties, and
c. bioassay and dose assessment for internally contaminated individuals.
An incomplete list may include the following specific manuals:
• Screening for highly contaminated casualties using a handheld detector.
• Screening for highly contaminated casualties using a personal portal monitor.
• Early triage for internally contaminated casualties using nose blow before 
removing external contamination.
• Early triage for internally contaminated casualties using facial swipe or nasal 
swab before removing external contamination.
• Early triage for internally contaminated casualties using a portable whole-body 
counter (WBC) after removing external contamination.
• Early triage for internally contaminated casualties using a personal portal 
monitor after removing external contamination.
• Early triage for internally contaminated casualties using epidemiological data 
(e.g. location at the time of the incident and how much time spent there).
• Thyroid monitoring and dose assessment.
• Whole body and partial body monitoring and dose assessment (technique 
specific manuals).
• Urine/fecal bioassay and dose assessment (radio-nuclide specific manuals).
It should be noted that any meaningful assessment of internal contamination involves first 
the removal of external contamination. If initial screening shows that an individual is 
contaminated, removal of the outer layer of clothing and external decontamination of the 
individual should be performed prior to any attempt for internal contamination assessment.
Special populations (e.g. children, pregnant women, nursing mothers, the elderly, people 
with physical or mental disabilities, ethnic groups with cultural or linguistic barriers) need 
special attention when performing population monitoring, as they may be more sensitive to 
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radiation exposure than the average population and/or require special considerations during 
the screening, triage, decontamination and assessment.
Experiences from both the Chernobyl and Fukushima accidents show that only robust 
techniques work well for population monitoring. Thus, it is necessary to evaluate, in 
advance, the accuracy and uncertainty of the methods and techniques to be used in response 
to a large-scale RN emergency. This may include a consideration of the physical 
characteristics of all potential subjects for direct measurements and the information required 
for improving dose estimations (e.g. age, sex, height, weight, behavior). To validate these 
robust monitoring techniques, more sophisticated measuring methods/techniques may be 
used for selected persons or/and groups. This WG can carefully review and discuss many 
lessons learned from the Fukushima accident(27) and initiate a new project to address those 
issues.
MONITORING AND DOSE ASSESSMENT FOR CHILDREN
Children, as one of the most vulnerable populations during an RN emergency, may have a 
higher risk of being contaminated by radioactive materials, receive higher doses per unit 
intake compared with adults, are more sensitive to radiation health effects, and may suffer 
more significant psychosocial impacts than adults. Thus, children should be of more concern 
than adults for their potential exposure to radiation during an RN emergency. Extensive 
individual monitoring for children was carried out in past major RN emergencies, such as 
the Goiânia accident(28), the Chernobyl accident(29) and the Fukushima accident(30). It has 
been demonstrated that monitoring large numbers of children in an emergency situation can 
be challenging, both from the perspective of accommodating their needs as well as adapting 
protocols to account for various ages and body sizes. Experiences gained and lessons learned 
from these three accidents are summarized, while gaps and potential tasks for this WG to 
address are discussed.
The Goiania accident occurred on 13 September 1987 when a shielded teletherapy unit 
containing over 50 TBq of 137Cs was removed from its protective housing in a junk yard in 
Goiânia, Brazil. Fragments of the radioactive source were dispersed and many people were 
contaminated. The initial screening of 112 000 individuals, using survey detectors, revealed 
that 120 individuals were contaminated on their clothing and shoes, while another 129 were 
found to have both external and internal contamination(28). These 249 individuals, including 
many children, were further monitored through in vitro and in vivo bioassay.
The Goiânia accident resulted in experience in monitoring children for internal 
contamination. These include the following:
a. In vitro bioassay for young children (aged 1–2 years old) by counting excreta 
(urine and feces) collected on their disposable diapers(31).
b. In vivo bioassay for young children using whole-body counting, where a staff 
member stayed in the counting room when a child was counted to help the child 
cope with anxiety(31).
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c. In vivo bioassay of a new born baby, where a staff member lay in the counting 
position with the infant held over her body(32).
d. Treating children with Prussian Blue (Radiogardase®), where children of 4–9 
years old treated with 1–1.5 g d−1 divided into 2–3 equal doses showed an 
average reduction of biological half-life of 43%, while adolescents of 12–14 
years old received up to 10 g d−1 showed an average reduction of biological half-
life of 46%(31).
e. Adapting the biokinetic and dosimetric models for 137Cs developed by the Oak 
Ridge National Laboratory (ORNL) for assessing radiation doses to the Goiânia 
children, as the heights and weights of Goiânia children are lower than those 
considered standard for the respective ORNL age groups(33).
On 26 April 1986, the most severe nuclear accident in human history occurred at Chernobyl, 
in the former USSR. Many members of the public in Russia, Belarus and Ukraine were 
exposed to the radionuclides released from this accident, including radioiodine isotopes. 
During the following weeks, large-scale thyroid monitoring was performed involving more 
than 300 000 people, including children. The activity of 131I in the thyroid at the time of 
measurement, based on direct thyroid counting using a survey meter, was estimated for each 
individual. To calculate thyroid dose, it was assumed that the intake was from acute 
inhalation and chronic ingestion. For accurate dose assessment, it is important to identify the 
main intake route for each age group of the population. A technique for identifying the main 
intake route was developed based on the survey results(34). As young children inhale less air 
than adults but consume more milk and dairy products, chronic ingestion was a more 
important intake route for them; the activity of radioiodine in the thyroid of a child was not 
necessarily lower than that in the thyroid of an adult.
On 11 March 2011, the Fukushima Daiichi Nuclear Power Station was seriously damaged 
by the effect of gigantic tsunamis generated by the Great East Japan Earthquake, resulting in 
core melt-down due to the loss of cooling functions for the reactors. Significant amounts of 
radionuclides were released into the environment from the damaged reactors. However, the 
radiological impact on members of the public from the Fukushima accident is considered to 
be much lower than that from the Chernobyl accident thanks to timely evacuation and 
restrictions on food consumption(35).
The number of human measurements at the early stage of the Fukushima accident was very 
limited(36–39), making it difficult to reconstruct internal doses to residents in affected 
areas(40). The screening campaign for thyroid radiation exposure in children was performed 
by the local emergency headquarters in late March 2011(39). This campaign covered 1080 
children aged from 0 to 15 years old. A major problem discovered during this campaign was 
the measurement of the thyroid using non-spectrometric counting devices, such as survey 
meters, under a relatively high ambient radiation background. Net activity of 131I in the 
thyroid of each subject was obtained by subtracting the readings at the shoulder from that at 
the neck surface(39, 41), but this requires many considerations including the biokinetics of the 
incorporated radionuclides, the shielding effect on ambient radiation by the body and the 
counting statistics. Another problem identified during the measurement process was that the 
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placement of a detector probe on the neck surface may lead to a significant uncertainty. The 
counting geometry should be standardized while the calibration of the counting device 
should be age dependent.
Whole-body measurements of Fukushima residents were initiated by research institutes in 
late June 2011 at the request of Fukushima Prefecture(42). These measurements were 
performed mainly on children. However, those under 4 years old were not considered as it 
was difficult to measure them with WBCs; their parents (or relatives) were measured as 
surrogates instead. In order to avoid underestimating the internal dose from the intake of 
radioactive cesium (134Cs and 137Cs), it was assumed that the intake (acute via inhalation) 
occurred on March 12 when the first explosion happened at the nuclear power station. This 
assumption, however, might have led to a significant over estimation of the dose received for 
children based on the late measurements. A small residual activity (even close to the 
detection limits of the WBCs) often meant a large dose was estimated, as a significant 
fraction of radioactive cesium is cleared from the body in the first few days.
The WG on internal radiation contamination may consider initiating a project to address the 
above technical issues related to children monitoring and dose assessment, focusing on the 
important tasks, such as calibration of the measurement instruments for different age groups 
and implementation of age-dependent biokinetic/dosimetric models for internal dose 
assessment. The success of such a project would help fill a significant gap in responding to 
an RN emergency.
MEDICAL MANAGEMENT OF INTERNAL RADIATION CONTAMINATION
The medical consequences of an internal radiation contamination are usually described as 
long-term effects unless the intake is significant enough to cause short-term tissue reactions. 
However, medical treatment for internal contamination should be administered shortly after 
the contamination occurs as the efficacy of the treatment may be compromised by the delay. 
Therefore, following an RN emergency where internal contamination may be involved, rapid 
triage of the populations for potential internal contamination and efficient medical 
management is very important(43).
The WG on internal radiation contamination has a wide range of expertise (bioassay, 
dosimetry, medical management). The scientific knowledge and operational experience give 
this group the necessary competency to provide advice and assistance in medical 
management following an RN emergency. The group aims to update the recommendations 
on medical management of internal radiation contamination by analyzing current 
recommendations, identifying the knowledge and operational gaps and needs, and 
monitoring the progress on scientific and technological development.
Guidelines, manuals and tools on managing internal radiation contamination have been 
developed by national and international organizations, such as the Agence nationale de 
sécurité du medicament et des produits de santé (ANSM) and l’Autorité de sûreté nucléaire 
(ASN) in France, the Food and Drug Administration (FDA) and the National Council on 
Radiation Protection and Measurements (NCRP) in the US, Public Health England (PHE) in 
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the UK, the IAEA and WHO(4, 21, 44–47). These publications and tools exist in varied 
formats, provide non-consistent information for the indications of treatments and do not 
always offer sufficient guidance for practical use. The WG is going to review these 
publications and tools in detail, as done by Leiterer et al.(48), compile characteristics of 
currently recommended medical treatments, evaluate their conditions of application and 
limitations and identify the potential difficulties the responders/receivers may face when 
they perform a treatment for internal contamination which is relatively new to them. It is 
expected that new guidance may need to be developed with practical information for use by 
responders and medical personnel.
In the framework of European projects, such as the Treatment Initiatives after Radiological 
Accidents (TIARA)(49), previous reviews have revealed
a. disagreement on treatment decisions and protocols between countries, especially 
between neighboring countries where harmonization could facilitate the 
operational aspects of medical management following an RN emergency;
b. insufficiencies or absence in medical countermeasures for some radionuclides; 
and
c. the need for developing appropriate new treatments to address complex exposure 
situations, such as contamination of children, pregnant women or the elderly, 
potential contamination by a mixture of radionuclides and/or other chemicals, 
and potential contamination of a large number of people where medical 
treatments need to be timely available and easily administered.
Development of biokinetic models pertaining to medical treatment can improve the quality 
of intake and/or dose assessment so that better decisions on treatment or better evaluation of 
the treatment can be made. For example, DTPA (diethylene triamine pentaacetate, in either 
Ca or Zn form) has been used to increase excretion of actinides incorporated in the body. As 
the administration of DTPA affects the regular biokinetics of the actinides, the standard 
biokinetic models used to assess the intake and dose for an individual contaminated with 
actinides but administered with DTPA are inadequate. The European Radiation Dosimetry 
Group (EURADOS) is developing new biokinetic models to address this issue(50, 51). This 
WG may seek future collaborations with EURADOS on this topic.
In the past years, scientists have been seeking and testing new candidate molecules that 
could be used to decorporate radionuclides, identifying promising decorporation indications 
from licensed drugs that are already on the market and developing innovative pharmaceutical 
forms with antidotes drugs in use in order to treat an internal contamination involving one or 
several radionuclides. The WG is going to further review these studies, identify the ones 
with significant and/or promising indications, and propose new project(s), if feasible.
NEXT STEPS
The WG on internal radiation contamination has identified the gaps in monitoring, 
assessment and treatments based on the existing literature and the experience gained from 
past accidents. The WG will further discuss the feasibility of initiating a few projects to 
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address these gaps. It is worthwhile to note that work in risk communication during 
emergency response, is also being considered, with respect to messaging related to 
managing internal contamination. While general guidelines on risk communication during 
an RN emergency are already available(52), communicating the health risks from internal 
radiation contamination to patients as well as to responders and medical personnel may need 
to be specifically addressed.
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